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When the non-contrast-enhanced phase is unnecessary
in abdominal computed tomography scans? A retrospective
analysis of 244 cases*
Quando a fase sem contraste intravenoso é desnecessária nos exames de tomografia computadorizada
do abdome? Análise retrospectiva de 244 casos
Danilo Manuel Cerqueira Costa1, Priscila Silveira Salvadori1, Rodrigo da Fonseca Monjardim1, Elisa
Almeida Sathler Bretas2, Lucas Rios Torres2, Rogerio Pedreschi Caldana3, David Carlos Shigueoka4,
Regina Bitelli Medeiros5, Giuseppe D’Ippolito5
Objective: To evaluate the necessity of the non contrast-enhanced phase in abdominal computed tomography scans.
Materials and Methods: A retrospective, cross-sectional, observational study was developed, evaluating 244 consecutive
abdominal computed tomography scans both with and without contrast injection. Initially, the contrast-enhanced images
were analyzed (first analysis). Subsequently, the observers had access to the non-contrast-enhanced images for a second
analysis. The primary and secondary diagnoses were established as a function of the clinical indications for each study
(such as tumor staging, acute abdomen, investigation for abdominal collection and hepatocellular carcinoma, among
others). Finally, the changes in the diagnoses resulting from the addition of the non-contrast-enhanced phase were
evaluated. Results: Only one (0.4%; p > 0.999; non-statistically significant) out of the 244 reviewed cases had the
diagnosis changed after the reading of non-contrast-enhanced images. As the secondary diagnoses are considered, 35
(14%) cases presented changes after the second analysis, as follows: nephrolithiasis (10%), steatosis (3%), adrenal
nodule (0.7%) and cholelithiasis (0.3%). Conclusion: For the clinical indications of tumor staging, acute abdomen,
investigation of abdominal collections and hepatocellular carcinoma, the non-contrast-enhanced phase can be excluded
from abdominal computed tomography studies with no significant impact on the diagnosis.
Keywords: Computed tomography; Ionizing radiation; Abdomen; Contrast media.
Objetivo: Avaliar a necessidade da fase sem contraste nos exames de tomografia computadorizada de abdome. Mate-
riais e Métodos: Foi realizado estudo retrospectivo, transversal e observacional, no qual foram avaliados 244 exames
consecutivos de tomografia computadorizada de abdome realizados sem e com a injeção do meio de contraste. Procu-
rou-se estabelecer, mediante análise das fases com o uso do meio de contraste (primeira análise), e posteriormente
com o acréscimo da avaliação da fase sem meio de contraste (segunda análise), o diagnóstico principal e os secundá-
rios em função da indicação clínica do exame (estadiamento tumoral, abdome agudo, pesquisa de coleção abdominal
e hepatocarcinoma, entre outros). Foram medidas as mudanças nos diagnósticos principais e secundários, decorrentes
do acréscimo da fase sem meio de contraste. Resultados: Dos 244 casos avaliados, apenas um (0,4%; p > 0,999;
não significante) teve o seu diagnóstico modificado após a leitura da fase sem meio de contraste. Com relação aos
diagnósticos secundários, 35 exames (14%) foram modificados após a segunda análise, sendo: nefrolitíase (10%),
esteatose (3%), nódulo de adrenal (0,7%) e colelitíase (0,3%). Conclusão: Para as indicações clínicas de estadiamento
tumoral, abdome agudo, pesquisa de coleção abdominal e carcinoma hepatocelular, a supressão da fase sem meio de
contraste não apresentou impacto diagnóstico expressivo.
Unitermos: Tomografia computadorizada; Radiação ionizante; Abdome; Meio de contraste.
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INTRODUCTION
Currently, radiological studies represent
one of the main sources of exposure to ion-
izing radiation of artificial origin(1). In such
a context, computed tomography (CT) is
highlighted as one of the most important
radiological techniques for medical appli-
cations, whose utilization has significantly
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increased in the past decades(2). As a con-
sequence of the dissemination of such tech-
nique in the medical practice, a significant
increase has been observed in the radiation
dose to which patients who require diag-
nostic exams are exposed(1).
Currently, CT is responsible for slightly
over 15% of all diagnostic imaging diag-
nostic studies and for more than 75% of the
total radiation coming from imaging pro-
cedures to which the population is ex-
posed(3).
The risks associated with ionizing radia-
tions are proportional to the exposure(4).
Therefore, every diagnostic scan should be
performed under accurate clinical indica-
tion and relying on as low as reasonably
achievable radiation doses, without com-
promising diagnostic quality(5,6).
Innumerable studies have been devel-
oped with a view on reducing the radiation
dose in CT, by adopting several different
strategies(7,8). Among such strategies, the
suppression of some of the studies’ phases
seems to be a practical and safe way to
achieve dose reduction, since the reliabil-
ity and diagnostic accuracy of the exams are
maintained(9).
Currently, there is a wide range of spe-
cific abdominal CT protocols for the most
diverse clinical suspicions(10). Most of such
protocols utilize the non-contrast-enhanced
phase which precedes the contrast-en-
hanced phases. In spite of being widely and
universally adopted for determined clinical
indications, the use of such protocols have
implications related to radiation dose, im-
ages acquisition time and x-ray tube wear,
and would only be justifiable in case it
added supplementary data indispensable
for the establishment of an accurate diag-
nosis, thus positively interfering in the ap-
proach to patients and prognosis(9).
Abdominal CT scan protocols may in-
clude up to four or more phases. Each one
of these phases has specific objectives and
isolatedly or in conjunction allows the es-
tablishment of a diagnosis, increasing the
sensitivity and accuracy of the method. On
the other hand, the specific weight of each
one of those CT images acquisition phases
and notably the value of the non-contrast-
enhanced phase in such a context are not
clear for the main clinical indications. The
evaluation of the usefulness of this phase
in the study of abdominal organs would
open the opportunity to suppress it in cer-
tain clinical situations, thus reducing the
radiation dose absorbed by the patient and
the inherent potential risks of the method.
Thus, the present study is aimed at
evaluating the need for the non-contrast-en-
hanced phase in different abdominal CT
protocols as well as its impact on the diag-
nosis.
MATERIALS AND METHODS
The present study was approved by the
Committee for Ethics in Research of Escola
Paulista de Medicina – Universidade Fede-
ral de São Paulo (EPM-Unifesp), and the
need for terms of free and informed con-
sent was waived considering the retrospec-
tive nature of the study.
In the period between August and No-
vember 2011 an observational, a cross-sec-
tional and retrospective study was under-
taken evaluating 244 consecutive abdomi-
nal CT scans. Of those CT studies, 107
(43.8%) were from male patients and 137
(56.2%) were from women. The mean pa-
tients’ age was 66.2 years, ranging between
18 and 88 years. Of the total of 244 scans,
35.5% were performed in emergency ser-
vice patients, 34.2% in inpatients, and
34.2% in outpatients.
Inclusion criteria were patients above 18
years of age, with spontaneous request for
abdominal CT scan with indication for uti-
lization of intravenous contrast agent. Ex-
clusion criteria were patients younger than
18 years, with indication for non-contrast-
enhanced abdominal CT scans, or with
contraindication for utilization of iodinated
contrast agents. Patients whose indication
for the scan was investigation of hematuria
were also excluded, considering the well
established theoretical groundings in litera-
ture advocating the need for non-contrast-
enhanced phase in such cases(11,12).
All the scans were performed in a
multidetector Brilliance 64® CT equipment
(Philips Medical Systems; Best, The Neth-
erlands), following the protocols included
in the Routine Procedures Manual of the
CT Unit of the Department of Imaging Di-
agnosis of the authors’ institution (avail-
able at http://ddi.unifesp.br/medicos-e-
profissionais-da-saude/193/exames/). The
intravenous contrast injection was made by
means of an automated injection pump, at
a velocity of 3–4 ml/s and at a ratio of 1.5–
2 ml/kg of weight, depending upon the io-
dine concentration, and with a maximum
volume of 150 ml. The triggering time for
the different contrast-enhancement phases
(arterial, portal and equilibrium) was estab-
lished based upon the automatic tracking of
contrast medium peak flow in the aorta.
The following technical parameters were
utilized: a) collimation of 64 × 0.625 mm;
b) 120 kVp; c) mAs established as a func-
tion of automatic modulation of radiation
dose; d) pitch of 0.891; e) reconstruction
thickness of 3.0 mm.
After the contrast agent injection, the
images were acquired in the arterial, por-
tal and equilibrium contrast-enhancement
phases (respectively, between 15–30 sec-
onds, 60–80 seconds and 3–5 minutes af-
ter the start of contrast medium administra-
tion), according to the clinical indication
and following the scan protocols of the
service. Rectal or oral administration of the
contrast agent was made as described by the
institutional CT scan protocol.
The radiation dose was controlled by
means of automatic dose modulation avail-
able in the CT apparatus, and expressed as
dose length product (DLP) in mGy.
The DLP represents the radiation dose
of one CT slice multiplied by the extent of
the scan and is measured in mGy/cm. The
effective radiation dose (estimating the to-
tal risk for stochastic effects induction on
an irradiated organ due to radiation expo-
sure) can be calculated by multiplying the
DLP by a correction factor as a function of
the studied anatomical region. Such correc-
tion factor is utilized for the calculation of
the effective dose (expressed in mSv), and,
in abdominal CT scans, it ranges between
0.015 and 0.018(13). In the present study the
calculation was made with a correction fac-
tor corresponding to 0.015.
The result obtained from such calcula-
tion is not the exact value of estimated ra-
diation, but it can be utilized as a reference
value at a given CT service, considering the
great practical difficulty in measuring an
exact dose per patient because of the wide
range of variables involved in the calcula-
tion, inherent to the patient (for example:
body mass index, abdominal circumfer-
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ence, irradiated organ) and to the utilized
technical factors (for example: kV, mAs,
pitch)(14).
All images were interpreted on a Syn-
apse® PACS/3D (FujiFilm; USA) worksta-
tion, by one radiologist from a five-mem-
ber team, all of them with at least three-year
experience in abdominal radiology, who
issued reports initially based only on the
images acquired in contrast-enhanced
phases, without evaluating the non-con-
trast-enhanced phase (first phase), and sub-
sequently combining the findings of all the
phases, including the non-contrast-en-
hanced phase (second analysis).
The observers had previous access to
the data on the medical requests for each
CT scan, and, at the first and second analy-
sis, classified the tomographic diagnoses
into primary and secondary diagnoses, ac-
cording to their clinical priority and impor-
tance for the patient. The primary diagnoses
were those directly related to the clinical in-
dication for the scans or which justified the
clinical condition of the patient. The sec-
ondary diagnoses were established by con-
sensus between observers and based on
data in the literature(15).
At the end of each evaluation, each one
of the five observers established whether
there were changes in their primary and sec-
ondary diagnoses between the first and sec-
ond analyses, i.e., whether the interpreta-
tion based on the analysis of the images ac-
quired in the non-contrast-enhanced phase
modified the diagnosis, as compared with
the first analysis.
Statistical analysis
The frequency of changes in the primary
and secondary diagnoses was measured,
according to the clinical indication, as the
first and second analyses were compared.
An extension of the Fisher’s exact test
was utilized to evaluate the changes in the
primary diagnoses, considering results with
p < 0.05 as significant. As regards second-
ary diagnoses, the proportion of cases of
change of diagnosis considering the total
number of CT scans was evaluated.
RESULTS
The present study included 244 patients
evaluated according to the following clini-
cal indications: neoplasm, including stag-
ing, re-staging and primary tumor investi-
gation in 122 patients (50%); acute abdo-
men in 45 patients (18%); investigation of
intracavitary collection in 38 patients
(15%); investigation of hepatocellular car-
cinoma (HCC) in 19 patients (7%), among
others. Among the 45 patients with clini-
cal indication for acute abdomen, 71%
were of the inflammatory subtype; 14%, of
the perforative type; 5%, of the obstructive
type; 5%, of the hemorrhagic type; and 5%
were vascular type. The protocols directed
towards investigation of adrenal nodule,
trauma and foreign body, classified as
“other”, in spite of also being evaluated in
relation to the primary diagnosis, were not
submitted to statistical analysis, consider-
ing the insufficient number of patients.
Furthermore, in such a group, no change
was observed in the primary diagnoses.
The mean radiation dose per phase was
835 mGy/cm (DLP), corresponding to an
estimated effective radiation dose of 12.5
mSv per phase.
Among the 122 patients whose clinical
indication was neoplasm, only one (0.8%)
of them had the diagnosis modified after
evaluation of the non-contrast-enhanced
phase (second analysis), without statistical
significance (p > 0.999). The scans with
protocols directed towards investigation of
acute abdomen, intracavitary collection and
hepatocellular carcinoma did not present
changes in the primary diagnoses.
Of the 244 patients, 35 (14%) had their
secondary diagnoses modified for the dif-
ferent clinical indications, namely: a) neph-
rolithiasis (25 patients, 10%); b) steatosis (7
patients, 3%); c) cholelythiasis (1 patient,
0.3%); d) adrenal nodule (2 patients, 0.7%).
DISCUSSION
Over the past years, an increasing utili-
zation of CT scans has been observed. Such
dissemination of the utilization of CT con-
tributes for the increase in the exposure of
patients to significant doses of ionizing
radiations, whose potential harmful and
deleterious effects to health cannot be ig-
nored or underestimated. The risk/benefit
ratio from such an exposure must be care-
fully evaluated with a view on the prin-
ciples of radiological protection to patients
and on the optimization of the protocols
and clinical practices(2,3,5).
Many studies have been undertaken
with the objective of reducing the radiation
dose in abdominal CT scans, by adopting
several strategies(9,16–18).
Some authors have reported that the di-
agnostic accuracy of imaging methods for
certain diseases is not impaired as one or
more scan phases are suppressed. In 2004,
Imbriacco et al.(18), evaluating patients with
suspected pancreatic neoplasia, demon-
strated that the utilization of a single con-
trast-enhanced phase in multislice CT is an
effective technique for diagnosis and stag-
ing of such type of tumor. Iannaccone et
al.(8), in 2005, reported that the combined use
of the arterial, portal and equilibrium phases
present sensitivity and positive predictive
value of 92.8% and 97.3%, respectively, for
detection of HCC in cirrhotic patients, con-
cluding that the non-contrast-enhanced
phase does not add value to justify its uti-
lization for the investigation of such tu-
mors. In 2008, Leite et al.(9) evaluated 100
patients with undefined clinical indication
or in tumor staging/re-staging, demonstrat-
ing that the non-contrast-enhanced phase is
not indispensable for such evaluations.
In 2010, other authors such as Kim et
al.(17), in a prospective study whose gold-
standard was liver biopsy, that the non-con-
trast-enhanced phase could be suppressed
in the evaluation of hepatic steatosis, being
replaced by the portal phase, with high sen-
sitivity and specificity.
With a view on this contemporary and
poorly consolidated theme, particularly in
the Brazilian literature, the authors of the
present study tried to contribute by focus-
ing on a different approach, i.e., instead of
focusing on a determined disorder or clini-
cal situation, they approached a wide range
indications for CT scans in the routine of a
CT service, with the purpose of evaluating
the impact of the non-contrast-enhanced
phase on the main CT scan protocols.
As regards the primary diagnosis, the
second analysis added value in only one of
the 224 cases of the four main groups of
clinical indications (investigation of pri-
mary tumor, suspicion of acute abdomen,
investigation of intracavitary collection and
HCC detection); in the remaining 20/244
cases, no change was observed in the pri-
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mary diagnoses after the second analyses.
The patient who benefited from the second
analysis underwent CT scan for colon can-
cer staging. The initial diagnosis (after the
first analysis) indicated the presence of an
indeterminate renal nodule. The final diag-
nosis (after the second analysis) demon-
strated the presence of a cyst with dense
contents, on account of its intermediate
density at the non-contrast-enhanced phase
(52 HU) and absence of enhancement at the
contrast-enhanced phases(19) (Figure 1).
According to the observer, the remaining
imaging findings were normal, with no sign
of metastatic dissemination of the colon
cancer to other organs. In spite of the fact
that such change in the diagnosis was con-
sidered as relevant, some considerations are
necessary.
Renal metastases from colon tumors are
rare events, Cases of metastasis from colon
cancer generally are observed in other or-
gans(20,21), a fact which was not observed in
that particular case, and making the diag-
nosis of metastasis by implantation in the
kidney unlikely in such a context.
Additionally, another strategy could be
utilized to differentiate a solid renal lesion
from a hyperdense cyst. Chung et al.(22)
have evaluated 43 histopathologically con-
firmed renal cysts and demonstrated that
the absence of significant enhancement
throughout the various contrast-enhanced
phases is indicative of cystic lesion, even
in cases where the pre-contrast phase is not
available. In the analysis of the present
case, the renal nodule classified as indeter-
minate at the first analysis, presented simi-
lar density at the post-contrast phases, con-
tributing to the hypothesis of actually be-
ing a cyst.
As regards secondary diagnoses, the au-
thors observed some changes that could be
better characterized in the second analysis
(with the addition of the non-contrast-en-
hanced phase).
In two non-oncologic patients (scans for
investigation of trauma and acute abdo-
men), adrenal nodules < 1.5 cm were iden-
tified, and were indeterminate at the con-
trast-enhanced phase, and compatible with
adenomas according to the density mea-
surement obtained at the non-contrast-en-
hanced phase. In such cases, where the
contrast-enhanced phase does not allow for
an accurate diagnosis, it is recommended
that the patient be recalled for a new evalu-
ation with a non-contrast-enhanced phase
and, if necessary, with a protocol directed
towards the study of adrenal nodule, thus
without any direct clinical impact(23). How-
ever, it is important to also consider that,
in spite of incidental adrenal nodules being
considered of high clinical relevance when
indeterminate(15), it has been demonstrated
that, in non-oncologic patients, the occur-
rence of malignancy is extremely rare in
such group of lesions(24).
As regards hepatic steatosis, which was
not identified by the first analysis in seven
of the 244 cases (3%), recent studies have
demonstrated that, by utilizing formulas or
evaluation methods, the portal phase, as
isolatedly utilized, presents an accuracy
similar to the non-contrast-enhanced phase
in the diagnosis of steatosis(17,25,26). In the
present study, by applying the formula pro-
posed by Kim et al.(17), all the seven patients
diagnosed with steatosis in the analysis of
the non-contrast-enhanced phase (liver
density lower than that of the spleen),
would have also been diagnosed by means
of isolated analysis of the portal phase (Fig-
ure 2). However, the formula developed by
Kim et al. is complex and depends upon
multiple measurements, which makes the
method non-practical in spite of its high
effectiveness. In a recent study undertaken
by the authors of the present study, such a
method was tried out in a simplified man-
ner, with good results and specificity above
90%, reducing the number of measure-
ments and entering the formula into a
Microsoft Office Excel® worksheet, thus
facilitating its use in the daily practice(27).
In spite of that, and considering that this
method is still poorly utilized, the authors
of the present study suggest that the non-
contrast-enhanced phase continues to be
utilized in the investigation of steatosis.
However, one should remember that mag-
netic resonance imaging and more recently
liver elastography (Fibroscan), have been
the methods recommended for such a pur-
pose(28,29), so the indication of CT as the
tool of choice for the diagnosis of hepatic
steatosis becomes questionable.
Renal calculi were identified in 25 pa-
tients by means of the non-contrast-en-
hanced phase. All of them were less than 5
mm in diameter, non-obstructive, and were
Figure 1. Change in the
primary diagnosis. Cyst
with dense contents,
characterized at the non-
con t r a s t - enhanced
phase (A), without sig-
nificant enhancement in
the portal (B) and equi-
librium (C) phases.
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found in asymptomatic patients (Figure 3),
and such signs suggest the adoption of an
expectant approach(30,31). Additionally, as
such cases are re-analyzed by manipulating
and changing the windowing width and
level in the available phases of the study,
the authors observed that it is possible to
enhance the detection of renal calculi in the
arterial and portal phases.
Another change in secondary diagnosis
occurred in a case of asymptomatic
cholelythiasis. It is a known fact that even
utilizing the non-contrast-enhanced phase,
the evaluation of cholelythiasis is limited
at CT, with sensitivity ranging between
25% and 88%, Ultrasonography is the
method of choice in the study of such a
disorder(32,33).
It is important to observe that in spite of
advocating the suppression of the non-con-
trast-enhanced phase in cases of acute ab-
domen, the CT scan protocols for pain in
the right iliac fossa (in the suspicion of
appendicitis) and in the left iliac fossa (in
the suspicion of diverticulitis), the non-
contrast-enhanced phase is performed in
the authors’ institution, and intravenous
contrast medium is utilized only in cases of
diagnostic doubt(10).
In the present study, a significant num-
ber of oncologic patients investigated for
acute abdomen and intra-abdominal infec-
tious process would benefit from the sup-
pression of the non-contrast-enhanced
phase, reducing the radiation dose, with no
impact on their diagnosis or approach.
Such a reduction in radiation dose would
range between 25% and 33% of the total
dose, as one considers scans performed
with four and three acquisition phases, re-
spectively. With the utilization of any pro-
tocol (three or four phases), one observes
a mean dose reduction per scan equivalent
to the effective dose of 12.5 mSv, because
of the suppression of the acquisition phase
without intravenous contrast agent injec-
tion. The management of the radiation dose
by means of a judicious utilization of the
different acquisition phases in protocols of
abdominal CT has been the object of sev-
eral recently published studies(34,35). The
number of patients evaluated in HCC in-
vestigation (19 patients) could have been
higher, but it was enough to verify, by
means of statistical tests, that there was no
impact in suppressing the non-contrast-
enhanced phase, as other studies have al-
ready suggested8). The authors believe that
further studies with larger samples will be
able to validate and confirm the initial re-
sults of the present study.
One limitation in the present study was
the wide range of analyzed protocols and
Figure 2. Changes in sec-
ondary diagnosis. A: Hepatic
steatosis diagnosed in the
non-contrast-enhanced
phase by the lower attenua-
tion of the liver (43 HU) in
relation to the spleen (46
HU). B: Same case of hepatic
steatosis retrospectively diag-
nosed in the portal phase
with regions of interest in the
liver, portal vein and aorta,
utilizing the formula proposed
by Kim et al. and with the
simplified calculation method
proposed by the authors(27).
Figure 3. Change in secondary diagnosis. Renal lithiasis (arrow) diagnosed only in the second analysis, with the non-contrast-enhanced phase. A: Non-con-
trast-enhanced phase. B: Portal phase.
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several clinical indications, which led to a
reduced number of patients in some groups
(for example, investigation for adrenal nod-
ules, trauma and foreign body), a fact
which impaired the statistical analysis in
such cases. However, the present study
describes the habitual hospital routine of
abdominal CT scans in the proposed pe-
riod, justifying the low prevalence of such
mentioned indications. Another limitation
was related to the fact that the diagnostic
accuracy of the two analyses were not mea-
sured, a fact which did not allow the assess-
ment of the method’s effectiveness as the
non-contrast-enhanced phase is sup-
pressed. However, in order to measure the
accuracy of a diagnostic method it is nec-
essary to utilize a test or reference standard,
which is not practical in a great number of
clinical situations in the daily practice and,
therefore, could not be utilized in the
present study.
Finally, another criticism could be re-
lated to the fact that only experienced ob-
servers were utilized. Further studies, com-
paring the results obtained by the analyses
performed by observers with different
training levels may clarify such issue.
CONCLUSION
Based on the analysis of the present
study results, it is possible to conclude that
the non-contrast-enhanced phase can be
suppressed in abdominal CT scans proto-
cols aimed at investigating acute abdomen,
intracavitary collections, cancer staging
and re-staging as well as investigation of
HCC, without any expressive loss in the
diagnostic capability of the method.
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